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Simple Summary: The problem of antimicrobial resistance is prominent and new alternatives to
antibiotics are necessary. Bacteriophages are viruses that target host bacteria and can be used
efficiently for their antibacterial properties to solve the problem of antimicrobial resistance. In this
study, we explore ways to genetically modify T7 bacteriophage and make its tropism broader, so that
it can attack a higher variety of bacteria. We are using different methodologies to achieve this, among
of those bacteriophage recombineering using electroporated DNA (BRED), which seems to be the
most efficient.
Abstract: The recognition and binding of host bacteria by bacteriophages is most often enabled by
a highly specific receptor–ligand type of interaction, with the receptor-binding proteins (RBPs) of
phages being the primary determinants of host specificity. Specifically modifying the RBPs could
alter or extend the host range of phages otherwise exhibiting desired phenotypic properties. This
study employed two different strategies to reprogram T7 phages ordinarily infecting commensal K12
Escherichia coli strains to infect pathogen-associated K1-capsule-expressing strains. The strategies
were based on either plasmid-based homologous recombination or bacteriophage recombineering
using electroporated DNA (BRED). Our work pursued the construction of two genetic designs:
one replacing the gp17 gene of T7, the other replacing gp11, gp12, and gp17 of T7 with their K1F
counterparts. Both strategies displayed successful integration of the K1F sequences into the T7
genome, detected by PCR screening. Multiple methods were utilised to select or enrich for chimeric
phages incorporating the K1F gp17 alone, including trxA, host-specificity, and CRISPR-Cas-based
selection. Irrespective of the selection method, the above strategy yielded poorly reproducible phage
propagation on the new host, indicating that the chimeric phage was less fit than the wild type
and could not promote continual autonomous reproduction. Chimeric phages obtained from BRED
incorporating gp11-12 and gp17, however, all displayed infection in a 2-stage pattern, indicating the
presence of both K1F and T7 phenotypes. This study shows that BRED can be used as a tool to quickly
access the potential of new RBP constructs without the need to engineer sustainably replicating
phages. Additionally, we show that solely repurposing the primary RBP is, in some cases, insufficient
to produce a viable chimeric phage.
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1. Introduction
The acceleration and spread of bacterial antibiotic resistance have enabled phage
therapy, the use of bacteriophages (phages) as therapeutics for resistant bacterial infections,
to develop and mature as a technology over the last two decades. Clinical trials are in
progress in both the U.S. and Europe [1] and procedures to access compassionate use of
phage therapy are already in place in many countries [2].
A potential hindrance to the large-scale use of phage therapy compared to traditional
antibiotics is the high host specificity of phages. Traditional antibiotics can often target
and treat entire classes of non-resistant bacteria, whereas phages are generally limited
to a smaller subset of closely related strains [3]. Thus, phage therapy is currently highly
individualised and requires identification of the pathogenic strain and subsequent selection
of a suitable phage strain. However, advancements in the field of molecular biology are
enabling researchers to edit genomes more efficiently than ever. Hence, there is a potential
to design and engineer recombinant phages with new phenotypic properties, such as an
altered or expanded host tropism.
A variety of methodologies have been developed for genetic engineering, many of
which rely on the well-established principles of homologous recombination. Possible phage
genome editing approaches include CRISPR-Cas, whole-genome synthesis, and genome
assembly in yeast or in cell-free TX-TL systems [4].
The phage specificity is primarily determined by the receptor-binding proteins (RBPs)
located on either tail fibres or tail spikes. These RBPs are the main focus of phage engineer-
ing, aiming to alter or expand the host tropism. A modular approach was employed by
Ando et al. [5] to reprogram wild-type Escherichia coli (E. coli) phage T7 to infect different
bacterial species, including Yersinia and Klebsiella. This approach included the synthesis of
the entire phage genome followed by Gibson assembly and expression in yeast cells [5].
Demonstrating a different approach, Yosef et al. [6] extended the host range of phage T7,
intended for DNA transduction and not replication, potentially targeting bacterial species
that would not normally support the propagation of phage T7. Individual recombinant
phage particles were engineered by homologous recombination, incorporating a specific
RBP gene into their genome. The recombinant phages showed susceptibility to multiple
Klebsiella pneumoniae and Salmonella enterica strains [6].
The primary goal of this work was to test multiple strategies to reprogram the host
specificity of the bacteriophage T7. The ease and safety of propagating phage T7 on E. coli
K12 allowed the accumulation of a vast amount of knowledge and the development of
numerous techniques for this phage. This could make phage T7 an ideal candidate system
to develop general phage traits (e.g., altered virulence or immunogenicity, or fusion with
fluorescent labels or tags) for basic research or biotechnological purposes. Such a collection
of altered T7 phages could execute specific phage-related tasks on other bacterial strains
after quickly modifying host specificity. We report here the application of two different
groups of strategies to reprogram the specificity of phage T7 for K1-capsule-expressing
E. coli hosts. We found that if multiple phage genome segments needed to be replaced,
linear-DNA mediated recombineering could yield the most promising results, even if the
complete gene set required for full phage viability was unknown.
2. Materials and Methods
2.1. Strains, Buffers, and Media
Two Escherichia coli strains were used for phage propagation: E. coli K-12 MG1655 [7]
and E. coli EV36, a K12/K1 hybrid developed by conjugation of the Hfr kps+ strain, which
was kindly provided by Dr Eric R. Vimr [8]. Phage T7 was obtained from Professor Ian
Molineux, and phage K1F was kindly provided by Dr Dean Scholl [9]. E. coli BW25113
∆trxA were obtained from the Keio collection and were kindly donated (from Professor
Alfonso Jaramillo’s lab). Bacteria were cultured in lysogeny broth (LB) [10]. Phage dilutions
were made in buffer Φ80+, containing 0.1 M NaCl, 0.01 M Tris (pH7.9), 0.01 M CaCl2, and
0.01 M MgCl2 [11]. The TBE buffer contained 45 mM Tris, 45 mM boric acid, and 1 mM
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EDTA [10]. The TE buffer contained 10 mM Tris and 1 mM EDTA. Agar was used in a
concentration of 1.5% in plates. SeaKem LE agarose (Lonza, Basel, Switzerland) used at
0.5% was applied as soft agarose overlay, always supplemented with 5 mM CaCl2 and
5 mM MgSO4. Antibiotics were used in the following end-concentrations: Ampicillin
(Ap): 50 µg/mL, Chloramphenicol (Cm): 25 µg/mL, Kanamycin (Km): 25 µg/mL. If not
indicated otherwise, chemicals were obtained from Sigma-Aldrich (St. Louis, MO, USA).
2.2. Plasmids
For plasmid-mediated phage engineering, the donor DNA encoding a chimeric gp17,
constructed by Aurelija Grigonyte [12], was further synthesised as a G-block by Integrated
DNA Technologies (Leuven, Belgium) and cloned into pSB6A1 (iGEM http://parts.igem.
org/Part:pSB6A1, accessed on 4 March 2021) using a Gibson assembly to make pSB6A1_T7-
K1Fgp17. The G-block sequence is available in Supplementary Table S1.
Recombineering of linear fragments was mediated by λ-Red recombinases expressed
from the pORTMAGE2 plasmid after heat-induction [13]. The plasmid pORTMAGE2 was
a kind gift of Dr Ákos Nyeges.
Plasmids pCas9_T7gp17 and pCas9_T7gp17-2, used for counterselection against wild-
type T7 phages, were constructed as described elsewhere [14]. Briefly, two complementary
oligonucleotides (listed in Table S1) encoding the spacers with appropriate overhangs were
phosphorylated, hybridised, and ligated into BsaI-digested pCas9 plasmids. The plasmid
pCas9 was a kind gift from Prof. Luciano Marraffini (Addgene plasmid # 42876).
2.3. General Phage Protocols
Phages T7 and K1F were routinely propagated on E. coli strains MG1655 and EV36,
respectively, using the protocol described earlier [15]. During all cases of phage growth,
the liquid medium and soft agarose contained 5 mM CaCl2 and 5 mM MgSO4. For phage
titering, a log10 serial dilution of the phage suspension was made and 10 µL of each
dilution step was pipetted on top of solidified soft agarose, which contained the target
bacterial strain at a 107/mL initial concentration. Plaques were counted after incubating
the plates (4 h for K1F, 16 h for T7) at 37 ◦C. For plaque PCR, plaques were aspirated with
cut-off 200 µL pipette tips and resuspended in 100 µL of TBE buffer. After a 16 h incubation
at 42 ◦C, 1 µL of the suspension was used in 10 µL PCR reactions to amplify various phage
genome segments.
2.4. Phage DNA Preparation
Phage genome purification was carried out using a modification of earlier protocols [10,16].
First, a fresh T7 phage lysate was made from a 100 mL culture of E. coli MG1655 by infecting
it with 4 × 105 phages at OD600 = 0.5. After lysis, DNAase (Promega, Madison, WI, USA)
and RNAaseA (Thermo Fisher Scientific, Waltham, MA, USA) were added at a final
concentration of 2 µg/mL each and incubated for 2 h at 37 ◦C. Next, NaCl was added
to a final concentration of 1 M and incubated for 2 h at 4 ◦C. Afterwards, the cell debris
was removed by centrifugation at 11,000× g for 15 min at 4◦ C. PEG8000 was added to
the supernatant at a final concentration of 10%, and the solution was incubated at 4 ◦C
overnight. The precipitated phage particles were recovered by pelleting at 11,000× g for
15 min at 4 ◦C. The supernatant was discarded and the pellet was resuspended in 400 µL
of TE. A quantity of 400 µL of buffered phenol was added, and the mixture was shaken for
10 min. After centrifugation at 10,000× g for 3 min, the aqueous (top) layer was recovered
and an equal amount of phenol was added for two more rounds of phenol extraction. After
phenol treatment, 300 µL of chloroform was added, shaken, and centrifuged for 1 min
at 10,000× g. The aqueous (top) layer was recovered for another round of chloroform
treatment. Next, 40 µL of 3 M sodium acetate was added to the recovered top phase, and
phage DNA was precipitated with six volumes of 100% ethanol at room temperature. DNA
was pelleted at 10,000× g for 12 min at room temperature. The supernatant was removed,
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and 1 mL of 70% ethanol was added and centrifuged for another 10 min. This step was
repeated one more time. The pellet was dried and resuspended in 100 µL of TE buffer.
2.5. Plasmid-Mediated Phage Editing
Recombinant phages were obtained by two consecutive rounds of homologous re-
combination. Each round consisted of adding the phage at an MOI of <1 to a log phase
bacterial culture at an OD600 of 0.3, previously transformed with the donor plasmid, and
incubated at 37 ◦C with rotation (200 rpm). Following the bacterial clearance, the lysate
was centrifuged at 3220× g for 15 min at 4 ◦C and subsequently passed through a 0.22 µm
pore size filter.
Selection for recombinant T7/K1F chimeric phages was performed using the standard
double overlay method with multiple approaches: marker-based selection on a thioredoxin-
deficient bacterial host, E. coli BW25113 ∆trxA; selection on a K1-capsule-expressing host;
and selection on a host expressing pCas9 targeting phage T7 wild-type tail fibres. Candidate
plaques were picked and screened by PCR using primers AS072 and AS081 to confirm the
presence of recombinant phages. The phages were recovered from the plaques into the TBE
buffer (as described above), were re-grown on the same host in a liquid medium, and were
re-plated in successive rounds with the intent of confirming the genotype and obtaining
pure phage clones.
2.6. Phage Selection Using pCas9
The phage mix obtained from the plasmid-mediated phage editing was grown on
E. coli EV36 harbouring either the pCas9_T7gp17 or the pCas9_T7gp17-2 plasmid. The
obtained phage lysates were titered and plated on E. coli EV36 in appropriate dilutions to
obtain individual plaques. Plaques were screened by PCR using primers T7tailFW and
K1FtailRev to detect recombinant phages.
2.7. BRED
Bacterial recombineering by electroporated DNA (BRED) [15] was used for the simul-
taneous modification of gp11-12 and gp17 genes of the T7 genome. The linear DNA used
for this purpose was generated in three steps: first, PCR-amplification of the five segments
shown in Figure 1; second, overlap-extension PCR-based fusion [17] of T7 left homology
with gp11-12 and gp17 with T7 right homology; third, the NEBuilder (New England Biolabs,
Ipswich, MA, USA) based assembly of three DNA fragments (T7 left homology + gp11-12;
gp13-16; gp17 + T7 right homology), each present at 0.18 pmol quantities (Figure 1). PCRs
were carried out with Phusion DNA polymerase (Thermo Fisher Scientific, Waltham, MA,
USA) at an annealing temperature of 58 ◦C. Primer sequences are listed in Table S1. The
entire completed NEBuilder reaction was mixed with 50 µL (ca. 110 µg) of the purified
T7 genomic DNA, and the mix was concentrated into 5 µL of TE by ethanol precipitation.
For BRED, 2 µL of this concentrated mix was electroporated into thermally induced E. coli
EV36/pORTMAGE2 electrocompetent cells. The electroporated cells were mixed with
3 mL of molten soft agarose, poured on LB + Ap plates, and incubated at 37 ◦C. The plaques
that appeared were analysed by plaque-PCR using the following primer pairs to identify
recombinants: gp10FWcheck + K1Fgp11Rev; K1Fgp12FW + T7gp13Rev; T7gp16FW +
K1Fgp17Rev(check); and K1fgp17FW(check) + T7gp19Rev. The obtained agarose plugs
were incubated at 42 ◦C overnight in 100 µL of TE for the diffusion of phages into the
buffer. A quantity of 50 µL of this solution was added to 5 mL log phase culture of E. coli
EV36pORTMAGE2 at 37 ◦C for phage propagation in an LB + Ap medium containing
5 mM CaCl2 and 5 mM MgSO4. After lysis, 1450 µL of the lysate was mixed with 50 µL of
chloroform, pelleted, and the aqueous (top) layer was recovered and filtered sterile with
a 0.22 µm pore size PVDF filter. For the next cycle of phage growth, 10 µL of this treated
lysate was added to 5 mL of naive E. coli EV36pORTMAGE2 log phase culture, creating a
500× dilution.
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In the alternative BRED protocol, 1 mL of electroporated culture from BRED was
directly mixed with 5 mL of E. coli EV36 cells. After 2 h of shaking at 37 ◦C, the lysate
was chlorofo m-treated and filtered sterile with a 0.22 µm pore size PVDF filter. For the
next cycle of phage growth, either 5 or 500 µL of the lysate was mixed with E. coli EV36
c rrespondi g to 1000× and 10× dilutions, respectively. Such growth cycles were repeated,
as described i the Results.
3. Results
In this project, we tested multipl strategi s to alter the ost sp cificity of phage T7,
to provi e the capability of infecting K1-capsule-expressing E. coli cells. As a starting
point, we analysed the growth and plaque-forming abilities of phage T7 and K1F on E. coli
MG1655 and E. coli EV36 strains displaying the K12 and K1 capsules, respectively. The
results, detailed in Table 1, indicated that the liquid-culture-mediated growth of T7 and
K1F is only possible on E. coli MG1655 and EV36 strains, respectively. However, plaque
formation in similar numbers was observed when switching the bacterial hosts (i.e., T7 on
EV36 and K1F on MG1655), albeit yielding smaller plaque diameters. This indicated that
the host specificities of the phages were not completely exclusive at the starting point of
our experiments.
Table 1. Growth properties of phages T7 and K1F.
T7 MG1665 EV36 K1F MG1665 EV36
canonical host yes no canonical host no yes
able to lyse yes yes(!) able to lyse yes(!) yes
plaque size * large small plaque size * small large
able to clear liquid
culture yes no
able to clear liquid
culture no yes
* Small plaques: 1–2 mm, large plaques: 13–15 mm in diameter after 12–16 h of incubation.
In the case of phage T7, binding to the cell surface is ensured by the six tail fibres.
Each tail fibre consists of three Gp17 proteins, all attached to the phage tail with their
N-termini. The phage tail is made up of a dodecamer of the Gp11 and a hexamer of the
Gp12 proteins. Gp7.3, an essential protein that is injected into the target cell, is also present
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in the tail in about 30 copies at an unknown location [18]. Our first strategy to completely
switch the specificity of phage T7 to K1 hosts targeted the tail fibre using plasmid-mediated
phage engineering, i.e., the growth of T7 on E. coli K12 cells harbouring a donor plasmid
(pSB6A1_T7-K1Fgp17) that carries a modified gp17 gene (Strategy I). This plasmid was
designed to include the 860 C-terminal residues of the K1F gp17 (possessing endosialidase
activity), thioredoxin (trxA) for positive selection, and two flanking phage T7 homology
regions (Figure 2). Sequence similarities between phage K1F and phage K1-5, another
K1 capsule-targeting phage, showed that the 204 amino acids (AAs) of the N-terminal
end of K1F Gp17 were not necessary for the correct folding of the enzymatic protein. We,
therefore, designed homologies to obtain a fusion protein where the 165 AA N-terminal
sequence of K1F gp17 is replaced with the 162 AA N-terminal end of T7 gp17.
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Figure 2. Strategy I, the genetic construct used for plasmid-mediated phage engineering. Large arrows depict genes. Small
arrows represent the following primers: 1: AS072; 2: AS081.
Propagation of phage T7 on E. coli K-12 (MG1655)/pSB6A1_T7-K1Fgp17 yielded a
phage lys te that c ntained detectable amounts of the fusion gp17 gene, as verified by PCR
using primers AS072 and AS081 (Figure 3). We applied three different strategies (IA-C) to
select for or enrich the recombinants within the phage mix (Figure 4). Strategy IA con isted
of phage growth on E. coli BW25113 ∆trxA, which lacks the thioredoxin gene. Since this
ge e is essential for phage replication, this host only allows the replication of phage
genomes that have acquired a copy of the trxA gene. Unfortunately, PCR-detectability of
the chimeric phage was lost over the first few rounds of phage propagation. The failure
of this method can be, in part, attributed to the fact that our ∆trxA strain did not carry a
K1 capsule and was, therefore, a suboptimal host for the propagation of the recombinant
phage. Attempting to boost phage propagation by providing the Gp17 protein of T7 in
trans did not solve this issue: the PCR signal also disappeared when growing the phages
on E. coli BW25113 ∆trxA + pT7_gp17.
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Strategy IB was more straightforward; it relied on the potentially improved ability of
the recombinant phage to lyse liquid cultures of E. coli EV36, a K1 capsule-expressing host.
We propagated the phage mix on liquid cultures of E. coli EV36, measuring phage titers
after every round of phage growth (even if no visible lysis occurred) using plated EV36.
Overall, the phages displayed a weak and poorly reproducible ability to grow in liquid
EV36 cultures. As apparent from Table 2, the titers measured in the course of three passages
strongly fluctuated; furthermore, during the first and third steps, we only recovered the
phages that we had mixed with the cells, indicating negligible phage propagation. A very
similar titer pattern was observed when starting not with the complete phage lysate, but
with a plaque obtained by plating the lysate on E. coli EV36. Importantly, in both series
of propagations, the phage mix lost the PCR-positivity by the third passage. Overall, we
concluded that propagating the phage mix on a K1-expressing host did not select for the
recombinant phages and could not even maintain the fusion gp17 genotype within the mix.
Table 2. Phage titers obtained by growing the recombinant phage mix (obtained via the recombination step shown on the
top of Figure 4) on E. coli EV36.





original K1F/T7 lysate (o) 1.6 × 1010 8 × 104 6 × 106 4 × 104
plaque derived K1F/T7 (1) ——— 2 × 104 6 × 106 1 × 104
In Strategy IC, we intended to further increase the pressure enriching recombinant
phages by applying CRISPR-Cas selection. We grew the phage mix on K1 capsule-
expressing hosts that carried the S. pneumoniae CRISPR-Cas machinery targeted against
either of two loci in the T7 gp17 gene, not present in the fusion gp17. Growth of the phage
mix on E. coli EV36/pCas9_T7gp17 or EV36/pCas9_T7gp17-2 was carried out both in
liquid culture and on plates, as described in the Methods. In both cases, the PCR-positivity
of the obtained phages was lost already after the first round of phage growth, irrespective
of the guide RNA used.
At this point, it became evident that the recombinant phage was not viable, or at least
its selective disadvantage compared to T7 was greater than the selective pressure exerted
by any of the three systems described above. A potential explanation and solution were
provided by the work of Ando et al. [5], who made similar observations when replacing
the gp17 gene of T7 with that of Klebsiella phage K11. In their work, the recombinant phages
were not viable unless gp11 and gp12 (the genes encoding the adaptor and the nozzle
proteins of the phage tail, respectively) were also replaced by their K11 counterparts. The
authors explained this requirement by the fact that the gp17-encoded tail fibres attach to the
interface between the Gp11 and Gp12 proteins. In light of this information, we redesigned
the donor plasmid to comprise the K1F derived gp11, gp12, and gp17 genes, as well as the
T7-derived gp13, gp14, gp15, and gp16 genes, as shown in Figure 1. The gene set was to
be flanked by two homologous ends allowing its entry into the T7 genome to replace the
native gp11-gp17 segment.
The donor plasmid was to be constructed as a four-way assembly (T7 left homology
+ gp11-12; gp13-16; gp17 + T7 right homology; bacterial artificial chromosome segment)
(Figure S1) using the method of Gibson et al. [19]. Gel electrophoresis of the reaction
product and PCR of the assembly joints indicated that the 14.2 kbp-long linear cassette was
most likely assembled (Figure S2). However, cloning it into pBeloBAC11 was not successful,
irrespective of whether E. coli MDS42, MG1655, or EV36 was used as a host, possibly due
to the toxicity of the construct. We, therefore, abandoned plasmid-mediated phage editing
and switched to Strategy II (Figure 5), which relies on bacteriophage recombineering using
electroporated DNA (BRED) [20]. This strategy builds on the fact that if purified phage
DNA is electroporated into an E. coli cell expressing the λ-Red recombinases, complete
phage genomes are assembled, yielding phage plaques within the bacterial lawn. If a linear
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DNA fragment with appropriate homology arms is included in the electroporation mix,
a certain fraction of the obtained plaques will contain recombinant phages, detectable by
plaque-PCR.
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For strategy IIA, E. coli EV36/pORTMAGE2 cells were electroporated with a mix of
T7 genomic DNA and the linear DNA fragment, as shown in Figure 5. After plating and
overnight growth, a total of 14 large (>10 mm) clear plaques were observable. We analysed
all plaques by four distinct PCR reactions (listed in Materials and Methods), screening
for the presence of the four T7/K1F joints. We found that all of the plaques contained at
least one of the two transgenic segments (i.e., gp11-12 or gp17) and four of them contained
both integrated into the T7 genome at the correct locus (Figure S3). Interestingly, small
plaques formed by wild-type T7 did not emerge (otherwise seen when the phage genome
is transformed without linear DNA). A double-positive plaque was picked, and the phages
were recovered and further propagated on liquid E. coli EV36 culture to verify its growth
ability and to enrich for virions containing the altered tail fibre. No lysis was observable in
the liquid medium, and the obtained plaques displayed the absence of gp17 and gp11-12
genes, as analysed by PCR. As an alternative (Strategy IIB), the phages recovered from
the plaque were grown on E. coli EV36/pORTMAGE2 to provide further possibilities of
recombination (by the λ-Red recombinases) and an increase rate of point mutations (by
the mutL allele). Growth on liquid E. coli EV36/pORTMAGE2 culture was possi le, as
the cells were c nsistently lysed. However, the transgenic segment of gp17 and gp11-12
l st n the first and second round of phage growth, respectively. Genes of the T7
phage were readily etectable by PCR in all rounds of phage growth (Figure S4). Th
continued lysis of the non-corresponding host by phage T7 is explained by the presence of
λ-Red recombinases. The expression of λ-Red in bacterial cells has recently been shown
to provide sufficient genetic reorganisation to lyse non-canonical hosts [21] (in a control
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experiment, we found that serial propagation of T7 on E. coli EV36/pORTMAGE2 liquid
cultures led to full lysis starting from the second round, without any linear DNA fragment
added; data not shown). The obtained phages nevertheless retained their ability to lyse E.
coli MG1655, as well. The activity of the K1Fgp17 was still present after the end of the serial
phage growth experiment in the form of two-stage plaques (Table 3, Figure 6), assuming
some lasting genetic change did occur. The same could not be seen when wild-type T7 was
assembled without K1F gene fragments.
Table 3. Summary of liquid bacterial lysis experiments with phages obtained by BRED.
Isolated from Plaque; Grown
without pORTMAGE





(Strategy IIA) (Strategy IIB) (Strategy IIC)
sustainable 1 no yes yes
sustainable on
pORTMAGE-free cells no no yes
clearing liquid culture no yes inconsistent 2
two-stage plaques yes yes yes
T7 tail genes present yes yes yes
K1F tail genes lost lost lost
1 Sustainability: capability of maintaining ≥106/mL phage titers during eight rounds of propagation on the indicated host. 2 Inconsistency:
phage propagation does not always result in the noticeable decrease of bacterial density.
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i ll , in Strategy II , e repeated the , b t i stead f l ti t t sf r e
terial mix and picking a plaque, we grew the bacteria (and the emerging phages) directly
in a liquid culture. This avoid the bottleneck introduced by randomly picking a plaque
and allows the competition of all putative recombinant and wild-type T7 phages within
a single m x. Growth to k place without antibiotic selection to prom te the quick loss of
the pORTMAGE2 plasmid. In this case, although bacterial lysis was not always visible
in the successive rounds of growth, phages were al ays detectabl , despite the lack of
pORTMAGE2. However, transgenic fragments wer quickly lost from the phage genome.
In all versions of Strategy II, the obtained plaques displayed a two-stage phenotype,
usually starting from the second or third round of growth. This meant a small, clear
centre surrounded by a turbid halo assuming the endosialidase activity of the K1F Gp17
protein [22] and the area of both kept increasing day-by-day (Figure 6). The observations
made with BRED experiments are summarised in Table 3.
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4. Discussion
Ever since the discovery of bacteriophages, knowledge concerning their host range
has been vital for biomedical applications for at least two reasons. On the one hand, phage
typing has long been used in microbial diagnostics to identify and classify the pathogens
isolated from bacterial infections [23]. On the other hand, phage therapy requires the
administration of phages capable of lysing the targeted pathogen. These needs explain the
increased attention paid towards phages that display a broad host range [24] or a host range
dependent on environmental factors, like temperature [25]. Later, spontaneously arising
host range mutants were often described [26,27], and with the advent of DNA sequencing,
the mutations responsible for the changes were also successfully identified [28,29]. With
the accumulation of sequencing data, comparative genomic studies of phage sequences
became possible. These revealed that in certain cases, exchanges of large genomic segments
are responsible for host switching [30]. Such information, along with the development of
phage engineering techniques, allowed the reprogramming of the host range of certain
phages by replacing host-range-determinant DNA segments [5,31]. Recently, the structure-
guided design of receptor-binding proteins has proven to offer an even more advanced
method of redirecting phages towards new hosts [32].
Our work fits into this series by providing an example of transferring one or more
large genomic segments between phages to alter the host tropism of the recipient phage.
In the course of this project, we tested two groups of strategies and two different genetic
constructs. Strategy I applied plasmid-based phage editing using either trxA (IA), host-
specificity (IB), or CRISPR-Cas-based selection (IC). Strategy II relied on BRED, using a
host-specificity-based selection of the recombinant phage. For Strategies IIA and IIB, a
single positive plaque was picked for the outgrowth of the putative recombinants on cells
either lacking or containing the λ-Red recombinase enzymes, respectively. Alternatively,
outgrowth of the entire phage lysate was attempted in the absence of λ-Red recombinase
enzymes for Strategy IIC.
To the best of our knowledge, this is the first published work aiming to tune phage
T7 tropism towards a K1-capsule-expressing host. This type of specificity-change could
bear clinical relevance in the future, when the rapid redirection of certain well-established
phages towards novel bacterial pathogens is required. From the molecular genetic point
of view, all six strategies accomplished the goal of producing detectable recombinant
constructs. Since well-established techniques were used for their selection, we attribute
the differences seen in the sustainability of the constructs not to differences of the selection
methods themselves but instead to the differences in the genetic design. Strategy I only
altered gp17 and left the 5′ end of the gene unchanged, while Strategy II applied the
complete exchange of the gp17 gene, along with that of gp11 and gp12. Since the latter
strategy yielded plaques that stood closest to the phenotype of completely lysing the new
host, we conclude that modification of either gp11 or gp12, or both, are required, in addition
to that of gp17 for the reprogramming of T7 to lyse K1-type hosts. The temporary nature of
such lysis, however, indicates that these genetic changes were still not sufficient to develop a
stable viable phage. Although this may be a shortcoming in some instances, it is satisfactory
for numerous experimental setups. The most prominent example is the engineering of
transducing phages or phage libraries, where efficient phage binding, DNA injection, and
the overcoming of defence mechanisms without autonomous phage replication are enough
to meet the requirements of practical applications [6].
Besides yielding unstable reprogrammed phages, our work also provides findings that
may help design future host switching experiments. First, we observed that the presence of
pORTMAGE is capable of allowing the growth of T7 on E. coli EV36 in liquid, irrespective
of donor DNA. This is in line with recent observations reporting that λ-Red recombinase
expression enables T7-like bacteriophages that do not normally propagate in E. coli to be
recovered following genome transfection [21]. Including donor DNA in the transformation
mix nevertheless exerted the temporary effect of yielding large clear plaques, which was
eventually lost. This means that (a) the genes responsible for efficient lysis of E. coli EV36
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are present; and (b) no pure, viable recombinant phage, which could pass on its genetic
composition to its offspring, was made. A mixed infection (T7 + recombinant phages) or
the integration of donor DNA into the bacterial host genome probably provided a genetic
background that resulted in the formation of the large clear plaques seen in the first plating
of Strategy IIA. Second, the observed two-stage plaques indicated the expression of the K1F
gp17 gene [22]. According to our hypothesis, gp17 was transiently expressed, and Gp17
enzymatically broke down the capsule, forming the turbid halo. This allowed the access of
T7 to the cell surface, which formed the clear centre of the two-stage plaques. However,
the gene construct is unstable; the proteins encoded by the construct cannot assemble to
yield viable phage particles alone. If a helper T7 is present, it can package the construct and
transfer, but again, it will not form viable particles alone. Therefore, recombinant constructs
are quickly lost from the phage mix. If the infected strain harbours λ-Red recombinases, it
can protect the transformed gp17 gene cassette and potentially integrate gp17 transferred
by the helper T7 phage into the bacterial genome. This allows transient production of
endosialidase, which, upon cell lysis, will break down the capsule of neighbouring cells.
The case of a mixed infection (T7 + recombinant phages) is supported by the fact that even
when propagating phages derived from isolated plaques declared recombinant by PCR, wt
T7 phages eventually become dominant and even exclusive after a few cycles of growth
on EV36. BRED is known to produce mixed plaques [20], since both WT and recombinant
phage genomes can be assembled in the same transformed host, which warrants that wt T7
is available as a helper phage during the initial growth of the recombinants. Transferring
to liquid phase, however, lowers the chances of co-infection due to the effect of dilution,
leading to the eventual cessation of the packaging of the recombinant phage genome into
T7-virions.
Finally, although a stable phage displaying host switching was not assembled in this
work, the large clear plaques are a strong indication that the necessary genes required for
serial lysis of a non-canonical host were all present. The T7 engineered phage, even though
it was not stable for the long term, still presented broader tropism and could efficiently
target EV36 presenting the K1 capsule, which is normally a host for the K1F phage. The
use of BRED for this purpose could be a quick way to test the potential use of a new tail
fibre without the need to engineer a stable phage.
Concerning the future, the information collected to this point could provide a basis
for the further enhancement of the hybrid construct, ultimately leading to a stable T7-
K1F chimeric phage. The two most straightforward explanations of the instability of our
chimera could be either the inadequate expression of genes present on the construct or
the inappropriate assembly of the encoded proteins due to their potentially incompatible
adjacent surfaces. Although we cannot completely exclude the former, earlier reports on
reorganizing genes within a phage genome indicated a relatively high level of robust-
ness [33,34]. Perhaps more likely is the incompatibility of neighbouring protein surfaces.
This would suggest that modular phage reorganization, which works quite effectively in
certain cases [5], is insufficient in others and demands sub-modular tuning for successful
host-switching. The accumulation of protein structural data and the development of novel
combinatorial genome editing techniques will certainly aid both the design-based and the
selection-based strategies aiming to solve such issues in the future.
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